Ajooni Biotech Limited has informed the Exchange about change in Management
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 15th Annual General Meeting held on September 29, 2025, shareholders approved the re-appointment of Mr. Partek Singh as a Director liable to retire by rotation, effective the same date. Mr. Partek Singh holds a Bachelor's degree in Commerce from Punjabi University, Patiala, and oversees the company's day-to-day operations, business policies, and strategies. The company confirmed he is not related to any existing Director or Key Managerial Personnel, and is not debarred by SEBI or any authority from holding a directorship. The voting results were declared on September 30, 2025. This is a routine governance action under Section 152(6) of the Companies Act, 2013.
This is a standard, procedural re-appointment with no change in board composition or management structure, so it is unlikely to have any material impact on the stock price or shareholder interests.